143 related articles for article (PubMed ID: 2142344)
1. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
Tanaka K; Turka LA; Kupiec-Weglinski JW; Milford EL; Ueda H; Diamantstein T; Carpenter CB; Tilney NL
Transplantation; 1990 Jul; 50(1):125-31. PubMed ID: 2142344
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Ueda H; Hancock WW; Cheung YC; Tanaka K; Kupiec-Weglinski JW; Tilney NL
Transplantation; 1990 Jun; 49(6):1124-9. PubMed ID: 2113725
[TBL] [Abstract][Full Text] [Related]
4. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
[TBL] [Abstract][Full Text] [Related]
5. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
Kupiec-Weglinski JW; Tilney NL; Stunkel KG; Grutzmann R; van der Meide PH; Di Stefano R; Diamantstein T
Transplantation; 1989 Jan; 47(1):11-6. PubMed ID: 2463699
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Kupiec-Weglinski JW; Mariani G; Tanaka K; Di Stefano R; Stünkel KG; Diamantstein T; Tilney NL
Cell Immunol; 1989 Oct; 123(1):148-57. PubMed ID: 2476241
[TBL] [Abstract][Full Text] [Related]
7. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL
Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.
Di Stefano R; Mouzaki A; Araneda D; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Exp Med; 1988 Jun; 167(6):1981-6. PubMed ID: 2968435
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence of a functional separation of alloreactive T lymphocytes from bystander cells infiltrating rat allografts. Interleukin 2 receptor-positive cells reacting with the monoclonal antibody ART 18 mediating second-set rejection.
Heidecke CD; Brauer R; Schneider-Eicke J; Schilling T; Wolff S; Diamantstein T
Transplantation; 1990 Jul; 50(1):101-6. PubMed ID: 2368130
[TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin 2 receptor b chain (P75)-specific monoclonal antibody on the generation of cytotoxic T lymphocytes and suppressor T cells in mixed lymphocyte culture.
Kusaka S; Sakagami K; Fujiwara T; Uda M; Orita K
Transpl Int; 1992; 5 Suppl 1():S698-702. PubMed ID: 14621914
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
Ueda H; Hancock WW; Cheung YC; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270
[TBL] [Abstract][Full Text] [Related]
12. Suppressor cells and T cell synergy in the primary MLR: interleukin-2 is required for the maintenance of rat CD8+ suppressor cells.
Van Sickler JT; Pickard LL; Salomon DR
Cell Immunol; 1991 May; 134(2):390-401. PubMed ID: 1708702
[TBL] [Abstract][Full Text] [Related]
13. Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.
Rich S; Carpino MR; Arhelger C
J Exp Med; 1984 May; 159(5):1473-90. PubMed ID: 6201587
[TBL] [Abstract][Full Text] [Related]
14. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
15. Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies.
Mouzaki A; Diamantstein T
Eur J Immunol; 1987 Nov; 17(11):1661-4. PubMed ID: 2445587
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the immune response to alloantigens: suppressor and helper T cells generated in the primary MLR of the rat.
Salomon DR; Cohen DJ; Carpenter CB; Milford EL
J Immunol; 1983 Sep; 131(3):1065-72. PubMed ID: 6193172
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
[TBL] [Abstract][Full Text] [Related]
19. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
Mouzaki A; Volk HD; Osawa H; Diamantstein T
Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.
Brooks JC; Hoskin DW
Transplantation; 1994 Nov; 58(10):1096-103. PubMed ID: 7974716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
